OPRL1 Antikörper
Kurzübersicht für OPRL1 Antikörper (ABIN5903985)
Target
Alle OPRL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Sequenz
- DLKIQTVKDQ PDEK
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
-
Immunogen
- DLKIQTVKDQPDEK.
-
-
anti-Opiate Receptor-Like 1 (OPRL1) (AA 1-47) antibody
OPRL1 Reaktivität: Human, Maus, Ratte WB, ELISA, IF (cc), IF (p), ICC, IHC (fro), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 323-370) antibodyOPRL1 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (Middle Region) antibodyOPRL1 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Meerschweinchen, Ziege, Pferd, Kaninchen, Schaf, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 110-212) antibodyOPRL1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (C-Term) antibodyOPRL1 Reaktivität: Human, Maus, Ratte WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 1-370) antibodyOPRL1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 110-212) antibodyOPRL1 Reaktivität: Human ELISA Wirt: Maus Monoclonal 2A11 unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- OPRL1 (Opiate Receptor-Like 1 (OPRL1))
-
Andere Bezeichnung
- ORL1
Target
-
